Organization
Ichnos Sciences
3 clinical trials
Clinical trial
A Phase 1, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 2001 in Subjects With Relapsed/Refractory Multiple MyelomaStatus: Not yet recruiting, Estimated PCD: 2027-07-01
Clinical trial
A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Participants With Relapsed/Refractory Multiple MyelomaStatus: Recruiting, Estimated PCD: 2027-05-01
Clinical trial
A Phase 1, First-in-Human, Multicenter, Open-Label, Two-Part Dose-Escalation and Cohort Expansion Study of Single-Agent ISB 1342 in Subjects With Previously Treated Multiple MyelomaStatus: Completed, Estimated PCD: 2023-12-15